logo

Cardiff Oncology Inc (CRDF) Stock: The Story of a 52-Week Stock Range

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Cardiff Oncology Inc’s current trading price is -30.53% away from its 52-week high, while its distance from the 52-week low is 374.47%. The stock’s price range during this period has varied between $0.94 and $6.42. The company, active in the Healthcare sector, saw a trading volume of around 1.05 million for the day, considerably lower average daily volume of 1.85 million observed over the last three months.

Cardiff Oncology Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $6.42 on 03/25/24, while the lowest price during the same period was $0.94 on 11/10/23.

How Financial Performance Impacts Market Capitalization

Cardiff Oncology Inc (CRDF) has experienced a quarterly rise of 182.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 199.27M and boasts a workforce of 32 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.92, with a change in price of +3.17. Similarly, Cardiff Oncology Inc recorded 1,227,344 in trading volume during the last 100 days, posting a change of +245.74%.

How CRDF’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRDF stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.

CRDF Stock Stochastic Average

As of today, the raw stochastic average of Cardiff Oncology Inc over the last 50 days is at 58.91%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 20.99%. Further, the company’s Stochastic %K and %D values for the last 20 days were 9.19% and 5.65%, respectively.

CRDF Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 201.35%. However, over the past six months, we’ve seen a weaker performance of 333.01%. The price of CRDF leaped by -16.48% over the last 30 days. And in the last five days, it has surged by 2.29%.

Most Popular